You're in the ER. The monitor shows a narrow complex tachycardia at 180 beats per minute. The patient is talking to you, blood pressure is fine, no chest pain, no shortness of breath. Stable. But their heart is racing like they just sprinted a marathon while sitting still.
What do you do first?
Most people jump straight to adenosine. And skipping what comes before it? In practice, push 6 mg, then 12 mg if needed. Done. But here's the thing — that's not actually the first step. That's where people get into trouble It's one of those things that adds up. That's the whole idea..
What Is Stable Narrow Complex Tachycardia
Let's get the definition straight. Narrow complex means the QRS is less than 120 milliseconds. The impulse is coming from above the ventricles — usually the AV node or atria — and conducting normally down the His-Purkinje system. Stable means the patient has adequate perfusion. No hypotension, no altered mental status, no ischemic chest pain, no acute heart failure, no signs of shock That's the part that actually makes a difference..
The rhythm is regular. Fast. Usually 150–250 bpm.
Most of the time, this is AV nodal reentrant tachycardia (AVNRT). Sometimes it's AV reentrant tachycardia (AVRT) — think WPW with an accessory pathway. Occasionally atrial tachycardia or atrial flutter with 2:1 block masquerading as SVT.
The distinction matters. But in the moment, with a stable patient, the initial approach is the same.
Why "Narrow Complex" Changes Everything
Wide complex tachycardia in a stable patient? So that's a different algorithm entirely. That said, could be VT. Consider this: could be SVT with aberrancy. Here's the thing — you treat it more cautiously. Amiodarone, procainamide, maybe cardioversion No workaround needed..
But narrow complex? Even so, the treatments are more specific. The differential narrows. And the first-line therapy isn't a drug at all.
Why It Matters / Why People Care
SVT sends people to the ER in droves. It's one of the most common dysrhythmias you'll see. Young, healthy people. In real terms, older folks on multiple meds. Think about it: post-op patients. People who just drank too much coffee and didn't sleep Worth knowing..
And here's what happens when you mismanage it: you give adenosine to someone with atrial flutter and 2:1 block — you get transient AV block, the flutter waves unmask, and suddenly the rate jumps to 300. Or you give verapamil to someone with WPW and pre-excited AF — you block the AV node, the accessory pathway takes over, and they degenerate into VF.
Real talk: people die from the treatment, not the rhythm.
But when you do it right? In real terms, vagal maneuver works. Adenosine works. On top of that, the patient converts, looks at you like you're magic, and goes home four hours later. That's the job But it adds up..
How It Works — The Actual Algorithm
Step One: Vagal Maneuvers
This is the step everyone skips. Or half-asses. And it's the only one with zero side effects.
The Valsalva maneuver. But not the "bear down like you're constipated" version. That barely works.
The Modified Valsalva — What Actually Works
Sit the patient up at 45 degrees. Have them blow into a 10 mL syringe (or a manometer if you're fancy) and maintain 40 mmHg of pressure for 15 seconds. Then — and this is the part everyone forgets — lay them flat immediately and passively raise their legs to 45 degrees for 60 seconds Most people skip this — try not to..
Why does this work better? Then the supine leg-raise phase — that's the kicker. Vagal tone spikes. Baroreceptors fire. The strain phase increases intrathoracic pressure, which increases venous return to the right heart but decreases it to the left. It auto-transfuses about 300 mL of blood from the legs to the central circulation, stretching the atria, triggering more vagal response, and — crucially — increasing stroke volume so the next Valsalva attempt (if needed) has more hemodynamic reserve That's the part that actually makes a difference..
The REVERT trial. Modified Valsalva converted 43% vs 17% for standard Valsalva. Lancet. That's not marginal. That said, 2015. That's massive.
And yet — I still see people having patients blow into an occluded straw. That said, or bear down against a closed glottis for three seconds. Or cough once. That's not a vagal maneuver. That's theater.
Carotid Sinus Massage — The Forgotten Option
Only in patients under 50. Consider this: one side at a time. Five to ten seconds. No carotid bruits. No history of stroke or TIA. Monitor on. Gentle pressure at the angle of the jaw.
Works about 20–25% of the time. But you need to be set up for it. And you need to know the contraindications cold.
Step Two: Adenosine — The Nuclear Option (That's Actually First-Line Drug)
Vagal maneuver failed. Now adenosine.
Six mg rapid IV push. Worth adding: the flush matters — adenosine's half-life is less than 10 seconds. Followed immediately by a 20 mL saline flush. If it sits in the line, it doesn't reach the heart.
No conversion? Still nothing? Wait one to two minutes. Also, twelve mg. Another 12 mg. That's the max Worth keeping that in mind..
What You're Actually Doing
Adenosine activates A1 receptors in the AV node. Hyperpolarizes the membrane. Opens potassium channels. Transiently blocks AV conduction — usually 3–10 seconds of asystole or high-grade AV block.
If the tachycardia depends on the AV node (AVNRT, AVRT), the circuit breaks. Rhythm terminates. Sinus rhythm resumes.
If it's atrial tachycardia or atrial flutter — the atria keep firing. You just get AV block. Which means the ventricular rate drops. You see the underlying atrial activity. Diagnostic. But not therapeutic Worth knowing..
The "Adenosine Didn't Work" Trap
Here's where people panic. They push another 12 mg. Then they call cardiology. Then another. Then they start a diltiazem drip.
Stop.
If two doses of 12 mg adenosine didn't convert it, it's probably not AVNRT or AVRT. Think atrial flutter with 2:1 block. Think atrial tachycardia. Think junctional ectopic tachycardia (rare, but happens post-cardiac surgery).
Don't keep pushing adenosine hoping the third time's the charm. It won't be. And each dose increases the risk of prolonged asystole, bronchospasm, or that terrifying moment when the monitor goes flat and stays flat for 20 seconds.
Step Three: Rate Control / Alternative Agents
Stable. Still in SVT. Adenosine failed or contraindicated (severe asthma, heart transplant — denervated heart, adenosine causes prolonged asystole).
Now you have options. And opinions vary.
Calcium Channel Blockers
Diltiazem 0.Reliable. Works fast. Then 5–15 mg/hr infusion. On the flip side, 25 mg/kg IV over 2 minutes. Hypotension is the main risk — especially in older patients or those on beta blockers The details matter here..
Verapamil 2.In practice, 5–5 mg IV over 2 minutes. Same idea. Even so, longer half-life. In practice, more negative inotropy. I prefer diltiazem. More titratable. Less myocardial depression.
Beta Blockers
Metoprolol 2.5–5 mg IV every 5 minutes x 3 doses. Esmolol drip if you want titration — 500 mcg/kg load, then 50–300 mcg/kg/min And that's really what it comes down to. Less friction, more output..
Beta blockers are great if there's underlying ischemic heart disease or thyrotoxicosis. But
...in patients with asthma, COPD, or severe bradycardia, beta blockers are contraindicated. Esmolol is particularly useful in unstable patients due to its ultra-short half-life, allowing rapid reversal if needed Practical, not theoretical..
Step Four: Cardioversion — The Last Resort
If rate control fails or the patient is hemodynamically unstable (e.g., hypotension, altered mental status, chest pain), electrical cardioversion becomes necessary. Synchronized cardioversion is delivered during the R wave to avoid inducing VF. Start with 100 J for atrial fibrillation/flutter, increasing to 200–300 J for refractory cases. Pre-shock medications like adenosine or verapamil may reduce energy requirements, but avoid calcium channel blockers in hyperkalemia or severe AV block.
Step Five: Post-Conversion Care
After successful cardioversion, monitor for recurrence. Hypokalemia, hypomagnesemia, or underlying thyroid disease (e.g., thyrotoxicosis) are common culprits. Correct electrolyte abnormalities and consider lidocaine infusion (1–1.5 mg/kg/hr) for recurrent arrhythmias. If the rhythm remains persistent, evaluate for structural heart disease, electrolyte imbalances, or reversible causes like pulmonary embolism.
Special Considerations
- Pediatric Patients: Adenosine dosing is weight-based (0.1–0.2 mg/kg). Avoid beta blockers in infants due to risk of bradycardia.
- Transplantation Recipients: Adenosine and verapamil are ineffective due to denervation; use amiodarone or ibutilide.
- Atrial Fibrillation: If cardioversion succeeds, address underlying causes (e.g., anticoagulation, rate control with digoxin or beta blockers).
Conclusion
SVT management hinges on a systematic approach: start with vagal maneuvers, escalate to adenosine as the first-line drug, and avoid pitfalls like repeated adenosine doses in non-AVNRT rhythms. When pharmacologic agents fail, electrical cardioversion is definitive but requires careful monitoring. Post-treatment, focus on identifying and addressing the root cause to prevent recurrence. Mastery of this algorithm ensures rapid, safe intervention, balancing efficacy with minimal risk. Always prioritize hemodynamic stability and tailor therapy to the patient’s unique physiology Turns out it matters..
